Clinical Trial Update: Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated the efficacy and safety of S-amlodipine at 2.5 mg and 5 mg in patients with hypertension. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• S-amlodipine (S-amlodipine)

Snippet

Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: Hypertension | Phase 4 | Status: COMPLETED